_id
691724f23c536f8df2316a90
Ticker
TYRA
Name
Tyra Biosciences Inc
Exchange
NASDAQ
Address
2656 State Street, Carlsbad, CA, United States, 92008
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://tyra.bio
Description
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.
Last Close
22.81
Volume
373290
Current Price
22.63
Change
-0.7891275756247249
Last Updated
2025-12-04T14:39:42.824Z
Image
https://logo.clearbit.com/tyra.bio
Ipo Date
2021-09-15T00:00:00.000Z
Market Cap
1158174464
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.989
Sentiment Sources
1
Rating
4.75
Target Price
32
Strong Buy
6
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
32944000
Operating Income
-32944000
Interest Expense
-
Pretax Income
-29868000
Net Income
-29868000
Eps
-0.5005466915728922
Dividends Per Share
-
Shares Outstanding
53372098
Income Tax Expense
-
EBITDA
-29737000
Operating Margin
-
Total Other Income Expense Net
3076000
Cash
61951000
Short Term Investments
212973000
Receivables
2200000
Inventories
-
Total Current Assets
281216000
Property Plant Equipment
7045000
Total Assets
301851000
Payables
1991000
Short Term Debt
456000
Long Term Debt
-
Total Liabilities
21342000
Equity
280509000
Depreciation
131000
Change In Working Capital
199000
Cash From Operations
-22380000
Capital Expenditures
39000
Cash From Investing
-14806000
Cash From Financing
647000
Net Change In Cash
-36539000
PE
-
PB
4.8139247971009835
ROE
-10.64778670203095
ROA
-9.89494816979238
FCF
-22419000
Fcf Percent
-
Piotroski FScore
1
Health Score
38
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
32944000
Quarters > 0 > income Statement > operating Income
-32944000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-29868000
Quarters > 0 > income Statement > net Income
-29868000
Quarters > 0 > income Statement > eps
-0.5005466915728922
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
59670757
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-29737000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
3076000
Quarters > 0 > balance Sheet > cash
61951000
Quarters > 0 > balance Sheet > short Term Investments
212973000
Quarters > 0 > balance Sheet > receivables
2200000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
281216000
Quarters > 0 > balance Sheet > property Plant Equipment
7045000
Quarters > 0 > balance Sheet > total Assets
301851000
Quarters > 0 > balance Sheet > payables
1991000
Quarters > 0 > balance Sheet > short Term Debt
456000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
21342000
Quarters > 0 > balance Sheet > equity
280509000
Quarters > 0 > cash Flow > net Income
-29868000
Quarters > 0 > cash Flow > depreciation
131000
Quarters > 0 > cash Flow > change In Working Capital
199000
Quarters > 0 > cash Flow > cash From Operations
-22380000
Quarters > 0 > cash Flow > capital Expenditures
39000
Quarters > 0 > cash Flow > cash From Investing
-14806000
Quarters > 0 > cash Flow > cash From Financing
647000
Quarters > 0 > cash Flow > net Change In Cash
-36539000
Quarters > 0 > ratios > PE
-0.5005466915728922
Quarters > 0 > ratios > PB
4.8139247971009835
Quarters > 0 > ratios > ROE
-10.64778670203095
Quarters > 0 > ratios > ROA
-9.89494816979238
Quarters > 0 > ratios > FCF
-22419000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
140000
Quarters > 1 > income Statement > gross Profit
-140000
Quarters > 1 > income Statement > operating Expenses
31452000
Quarters > 1 > income Statement > operating Income
-31452000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-28098000
Quarters > 1 > income Statement > net Income
-28098000
Quarters > 1 > income Statement > eps
-0.4718326820655269
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
59550771
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-31312000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
3354000
Quarters > 1 > balance Sheet > cash
98490000
Quarters > 1 > balance Sheet > short Term Investments
197781000
Quarters > 1 > balance Sheet > receivables
1700000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
302155000
Quarters > 1 > balance Sheet > property Plant Equipment
7235000
Quarters > 1 > balance Sheet > total Assets
321499000
Quarters > 1 > balance Sheet > payables
2245000
Quarters > 1 > balance Sheet > short Term Debt
441000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
19352000
Quarters > 1 > balance Sheet > equity
302147000
Quarters > 1 > cash Flow > net Income
-28098000
Quarters > 1 > cash Flow > depreciation
140000
Quarters > 1 > cash Flow > change In Working Capital
-1394000
Quarters > 1 > cash Flow > cash From Operations
-23680000
Quarters > 1 > cash Flow > capital Expenditures
31000
Quarters > 1 > cash Flow > cash From Investing
20866000
Quarters > 1 > cash Flow > cash From Financing
583000
Quarters > 1 > cash Flow > net Change In Cash
-2231000
Quarters > 1 > ratios > PE
-0.4718326820655269
Quarters > 1 > ratios > PB
4.460193044213578
Quarters > 1 > ratios > ROE
-9.299446957937693
Quarters > 1 > ratios > ROA
-8.739685037900584
Quarters > 1 > ratios > FCF
-23711000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
143000
Quarters > 2 > income Statement > gross Profit
-143000
Quarters > 2 > income Statement > operating Expenses
31850000
Quarters > 2 > income Statement > operating Income
-31850000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-28147000
Quarters > 2 > income Statement > net Income
-28147000
Quarters > 2 > income Statement > eps
-0.47436192363728596
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
59336550
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-31707000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
3703000
Quarters > 2 > balance Sheet > cash
100721000
Quarters > 2 > balance Sheet > short Term Investments
218222000
Quarters > 2 > balance Sheet > receivables
1800000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
324566000
Quarters > 2 > balance Sheet > property Plant Equipment
7468000
Quarters > 2 > balance Sheet > total Assets
343476000
Quarters > 2 > balance Sheet > payables
2500000
Quarters > 2 > balance Sheet > short Term Debt
426000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
19942000
Quarters > 2 > balance Sheet > equity
323534000
Quarters > 2 > cash Flow > net Income
-28147000
Quarters > 2 > cash Flow > depreciation
143000
Quarters > 2 > cash Flow > change In Working Capital
-3010000
Quarters > 2 > cash Flow > cash From Operations
-25458000
Quarters > 2 > cash Flow > capital Expenditures
14000
Quarters > 2 > cash Flow > cash From Investing
32026000
Quarters > 2 > cash Flow > cash From Financing
2187000
Quarters > 2 > cash Flow > net Change In Cash
8755000
Quarters > 2 > ratios > PE
-0.47436192363728596
Quarters > 2 > ratios > PB
4.150370985738747
Quarters > 2 > ratios > ROE
-8.699858438371237
Quarters > 2 > ratios > ROA
-8.194750142659167
Quarters > 2 > ratios > FCF
-25472000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
496000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
248000
Quarters > 3 > income Statement > operating Expenses
29744000
Quarters > 3 > income Statement > operating Income
-29744000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-25571000
Quarters > 3 > income Statement > net Income
-25571000
Quarters > 3 > income Statement > eps
-0.43433067462130504
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
58874497
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-29600000
Quarters > 3 > income Statement > operating Margin
-5996.774193548387
Quarters > 3 > income Statement > total Other Income Expense Net
4173000
Quarters > 3 > balance Sheet > cash
91966000
Quarters > 3 > balance Sheet > short Term Investments
249475000
Quarters > 3 > balance Sheet > receivables
2000000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
347463000
Quarters > 3 > balance Sheet > property Plant Equipment
7719000
Quarters > 3 > balance Sheet > total Assets
363558000
Quarters > 3 > balance Sheet > payables
590000
Quarters > 3 > balance Sheet > short Term Debt
412000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
20407000
Quarters > 3 > balance Sheet > equity
343151000
Quarters > 3 > cash Flow > net Income
-25571000
Quarters > 3 > cash Flow > depreciation
144000
Quarters > 3 > cash Flow > change In Working Capital
318000
Quarters > 3 > cash Flow > cash From Operations
-19590000
Quarters > 3 > cash Flow > capital Expenditures
6000
Quarters > 3 > cash Flow > cash From Investing
6958000
Quarters > 3 > cash Flow > cash From Financing
706000
Quarters > 3 > cash Flow > net Change In Cash
-11926000
Quarters > 3 > ratios > PE
-0.43433067462130504
Quarters > 3 > ratios > PB
3.882634371195188
Quarters > 3 > ratios > ROE
-7.451821501321576
Quarters > 3 > ratios > ROA
-7.03354072802689
Quarters > 3 > ratios > FCF
-19596000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-39.50806451612903
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
519000
Annuals > 0 > income Statement > gross Profit
-519000
Annuals > 0 > income Statement > operating Expenses
104177000
Annuals > 0 > income Statement > operating Income
-104177000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-86481000
Annuals > 0 > income Statement > net Income
-86481000
Annuals > 0 > income Statement > eps
-1.511436679103018
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
57217746
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-103658000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
17696000
Annuals > 0 > balance Sheet > cash
91966000
Annuals > 0 > balance Sheet > short Term Investments
249475000
Annuals > 0 > balance Sheet > receivables
2000000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
347463000
Annuals > 0 > balance Sheet > property Plant Equipment
7719000
Annuals > 0 > balance Sheet > total Assets
363558000
Annuals > 0 > balance Sheet > payables
590000
Annuals > 0 > balance Sheet > short Term Debt
412000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
20407000
Annuals > 0 > balance Sheet > equity
343151000
Annuals > 0 > cash Flow > net Income
-86481000
Annuals > 0 > cash Flow > depreciation
519000
Annuals > 0 > cash Flow > change In Working Capital
-729000
Annuals > 0 > cash Flow > cash From Operations
-69774000
Annuals > 0 > cash Flow > capital Expenditures
664000
Annuals > 0 > cash Flow > cash From Investing
-98403000
Annuals > 0 > cash Flow > cash From Financing
202137000
Annuals > 0 > cash Flow > net Change In Cash
33960000
Annuals > 0 > ratios > PE
-1.511436679103018
Annuals > 0 > ratios > PB
3.6183053180669735
Annuals > 0 > ratios > ROE
-25.202024764607998
Annuals > 0 > ratios > ROA
-23.78740118495536
Annuals > 0 > ratios > FCF
-70438000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
353000
Annuals > 1 > income Statement > gross Profit
-353000
Annuals > 1 > income Statement > operating Expenses
79945000
Annuals > 1 > income Statement > operating Income
-79945000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-69134000
Annuals > 1 > income Statement > net Income
-69134000
Annuals > 1 > income Statement > eps
-1.618878368830763
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
42704876
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-79588000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
10811000
Annuals > 1 > balance Sheet > cash
58006000
Annuals > 1 > balance Sheet > short Term Investments
145463000
Annuals > 1 > balance Sheet > receivables
700000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
211671000
Annuals > 1 > balance Sheet > property Plant Equipment
8154000
Annuals > 1 > balance Sheet > total Assets
225857000
Annuals > 1 > balance Sheet > payables
4662000
Annuals > 1 > balance Sheet > short Term Debt
280000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
21595000
Annuals > 1 > balance Sheet > equity
204262000
Annuals > 1 > cash Flow > net Income
-69134000
Annuals > 1 > cash Flow > depreciation
353000
Annuals > 1 > cash Flow > change In Working Capital
6360000
Annuals > 1 > cash Flow > cash From Operations
-50139000
Annuals > 1 > cash Flow > capital Expenditures
770000
Annuals > 1 > cash Flow > cash From Investing
-144605000
Annuals > 1 > cash Flow > cash From Financing
1537000
Annuals > 1 > cash Flow > net Change In Cash
-193207000
Annuals > 1 > ratios > PE
-1.618878368830763
Annuals > 1 > ratios > PB
4.536799841380188
Annuals > 1 > ratios > ROE
-33.84574712868766
Annuals > 1 > ratios > ROA
-30.60963352917997
Annuals > 1 > ratios > FCF
-50909000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
296000
Annuals > 2 > income Statement > gross Profit
-296000
Annuals > 2 > income Statement > operating Expenses
58927000
Annuals > 2 > income Statement > operating Income
-58927000
Annuals > 2 > income Statement > interest Expense
296000
Annuals > 2 > income Statement > pretax Income
-55325000
Annuals > 2 > income Statement > net Income
-51723000
Annuals > 2 > income Statement > eps
-1.2349135362357817
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
41883904
Annuals > 2 > income Statement > income Tax Expense
-3602000
Annuals > 2 > income Statement > EBITDA
-58631000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
3602000
Annuals > 2 > balance Sheet > cash
251213000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
257288000
Annuals > 2 > balance Sheet > property Plant Equipment
3543000
Annuals > 2 > balance Sheet > total Assets
266181000
Annuals > 2 > balance Sheet > payables
1145000
Annuals > 2 > balance Sheet > short Term Debt
140000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
8352000
Annuals > 2 > balance Sheet > equity
257829000
Annuals > 2 > cash Flow > net Income
-55325000
Annuals > 2 > cash Flow > depreciation
296000
Annuals > 2 > cash Flow > change In Working Capital
-5847000
Annuals > 2 > cash Flow > cash From Operations
-50285000
Annuals > 2 > cash Flow > capital Expenditures
559000
Annuals > 2 > cash Flow > cash From Investing
-559000
Annuals > 2 > cash Flow > cash From Financing
632000
Annuals > 2 > cash Flow > net Change In Cash
-50969000
Annuals > 2 > ratios > PE
-1.2349135362357817
Annuals > 2 > ratios > PB
3.525129899274325
Annuals > 2 > ratios > ROE
-20.060970643333373
Annuals > 2 > ratios > ROA
-19.431514646049116
Annuals > 2 > ratios > FCF
-50844000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
29
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
140000
Annuals > 3 > income Statement > gross Profit
-140000
Annuals > 3 > income Statement > operating Expenses
26288000
Annuals > 3 > income Statement > operating Income
-26288000
Annuals > 3 > income Statement > interest Expense
140000
Annuals > 3 > income Statement > pretax Income
-26294000
Annuals > 3 > income Statement > net Income
-26141000
Annuals > 3 > income Statement > eps
-0.6307983601317869
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
41441135
Annuals > 3 > income Statement > income Tax Expense
-153000
Annuals > 3 > income Statement > EBITDA
-26148000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-6000
Annuals > 3 > balance Sheet > cash
302182000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
304057000
Annuals > 3 > balance Sheet > property Plant Equipment
2089000
Annuals > 3 > balance Sheet > total Assets
306701000
Annuals > 3 > balance Sheet > payables
599000
Annuals > 3 > balance Sheet > short Term Debt
202000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
4964000
Annuals > 3 > balance Sheet > equity
301737000
Annuals > 3 > cash Flow > net Income
-26294000
Annuals > 3 > cash Flow > depreciation
140000
Annuals > 3 > cash Flow > change In Working Capital
-481000
Annuals > 3 > cash Flow > cash From Operations
-23745000
Annuals > 3 > cash Flow > capital Expenditures
661000
Annuals > 3 > cash Flow > cash From Investing
-645000
Annuals > 3 > cash Flow > cash From Financing
311348000
Annuals > 3 > cash Flow > net Change In Cash
286958000
Annuals > 3 > ratios > PE
-0.6307983601317869
Annuals > 3 > ratios > PB
2.9803193824423255
Annuals > 3 > ratios > ROE
-8.663504972873728
Annuals > 3 > ratios > ROA
-8.523284893104359
Annuals > 3 > ratios > FCF
-24406000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.5005466915728922
Valuation > metrics > PB
4.8139247971009835
Valuation > final Score
31.860752028990163
Valuation > verdict
60.5% Overvalued
Profitability > metrics > ROE
-10.64778670203095
Profitability > metrics > ROA
-10.621017296313154
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.07608312032769002
Risk > metrics > Interest Coverage
-251.48091603053436
Risk > final Score
-946
Risk > verdict
High
Liquidity > metrics > Current Ratio
114.92276256640784
Liquidity > metrics > Quick Ratio
114.92276256640784
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
35.39806955786422
Prev Valuations > 1
38.49629014261253
Prev Valuations > 2
41.17365628804812
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
21
Prev Risks > 1
24
Prev Risks > 2
30
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:21:08.119Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-10-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.5
Earnings History > 0 > eps Estimate
-0.5014
Earnings History > 0 > eps Difference
0.0014
Earnings History > 0 > surprise Percent
0.2792
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.47
Earnings History > 1 > eps Estimate
-0.53
Earnings History > 1 > eps Difference
0.06
Earnings History > 1 > surprise Percent
11.3208
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-29
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.47
Earnings History > 2 > eps Estimate
-0.4762
Earnings History > 2 > eps Difference
0.0062
Earnings History > 2 > surprise Percent
1.302
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-27
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.43
Earnings History > 3 > eps Estimate
-0.48
Earnings History > 3 > eps Difference
0.05
Earnings History > 3 > surprise Percent
10.4167
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.41
Earnings History > 4 > eps Estimate
-0.4
Earnings History > 4 > eps Difference
-0.01
Earnings History > 4 > surprise Percent
-2.5
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.32
Earnings History > 5 > eps Estimate
-0.41
Earnings History > 5 > eps Difference
0.09
Earnings History > 5 > surprise Percent
21.9512
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.35
Earnings History > 6 > eps Estimate
-0.46
Earnings History > 6 > eps Difference
0.11
Earnings History > 6 > surprise Percent
23.913
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-19
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.53
Earnings History > 7 > eps Estimate
-0.48
Earnings History > 7 > eps Difference
-0.05
Earnings History > 7 > surprise Percent
-10.4167
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-07
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.49
Earnings History > 8 > eps Estimate
-0.35
Earnings History > 8 > eps Difference
-0.14
Earnings History > 8 > surprise Percent
-40
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.31
Earnings History > 9 > eps Estimate
-0.34
Earnings History > 9 > eps Difference
0.03
Earnings History > 9 > surprise Percent
8.8235
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-04
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.28
Earnings History > 10 > eps Estimate
-0.37
Earnings History > 10 > eps Difference
0.09
Earnings History > 10 > surprise Percent
24.3243
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-22
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.31
Earnings History > 11 > eps Estimate
-0.36
Earnings History > 11 > eps Difference
0.05
Earnings History > 11 > surprise Percent
13.8889
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-03
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.3
Earnings History > 12 > eps Estimate
-0.41
Earnings History > 12 > eps Difference
0.11
Earnings History > 12 > surprise Percent
26.8293
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-04
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.36
Earnings History > 13 > eps Estimate
-0.32
Earnings History > 13 > eps Difference
-0.04
Earnings History > 13 > surprise Percent
-12.5
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-05
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.36
Earnings History > 14 > eps Estimate
-0.2
Earnings History > 14 > eps Difference
-0.16
Earnings History > 14 > surprise Percent
-80
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-03
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.24
Earnings History > 15 > eps Estimate
-0.21
Earnings History > 15 > eps Difference
-0.03
Earnings History > 15 > surprise Percent
-14.2857
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-03
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.72
Earnings History > 16 > eps Estimate
-0.29
Earnings History > 16 > eps Difference
-0.43
Earnings History > 16 > surprise Percent
-148.2759
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-09-15
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.24
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.24
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-28
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.04
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.04
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-2.0947
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-2.0947
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-12-31
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-1.8041
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-1.8041
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-30
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-1.8041
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-1.8041
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-30
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-1.2691
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-1.2691
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-1.067
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-1.067
Earnings History > 23 > surprise Percent
-
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAssessing Tyra Biosciences (TYRA) Valuation Following Key Executive Hires to Support Advancing Clinical Pipeline simplywall.st
Read more →Stock Report: Why TYRA stock remains a top recommendation - July 2025 Rallies & Stock Portfolio Risk Management moha.gov.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$32
Analyst Picks
Strong Buy
6
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 102.48% of the total shares of Tyra Biosciences Inc
1.
RA Capital Management, LLC(22.888%)
since
2025/06/30
2.
Alta Partners Management Company, L.P.(7.6558%)
since
2025/06/30
3.
Nextech Invest, Ltd.(7.6099%)
since
2025/06/30
4.
Bvf Inc(7.4004%)
since
2025/06/30
5.
Canaan Partners XI LLC(6.7698%)
since
2025/06/30
6.
COMMODORE CAPITAL LP(5.8164%)
since
2025/06/30
7.
TCG Crossover Management, LLC(5.4376%)
since
2025/06/30
8.
HHG PLC(5.3592%)
since
2025/06/30
9.
Vestal Point Capital LP(4.9815%)
since
2025/06/30
10.
Kynam Capital Management, LP(4.3717%)
since
2025/06/30
11.
BlackRock Inc(3.5524%)
since
2025/06/30
12.
Vanguard Group Inc(2.63%)
since
2025/06/30
13.
Farallon Capital Management, L.L.C.(2.1461%)
since
2025/06/30
14.
5AM Venture Management, LLC(1.7624%)
since
2025/06/30
15.
Sio Capital Management, LLC(1.5203%)
since
2025/06/30
16.
Orbimed Advisors, LLC(1.5097%)
since
2025/06/30
17.
Vanguard Total Stock Mkt Idx Inv(1.4908%)
since
2025/07/31
18.
iShares Russell 2000 ETF(1.1091%)
since
2025/08/31
19.
Balyasny Asset Management LLC(1.0946%)
since
2025/06/30
20.
Biotech Growth Ord(1.0885%)
since
2025/05/31
21.
Geode Capital Management, LLC(1.0641%)
since
2025/06/30
22.
Marshall Wace Asset Management Ltd(0.8032%)
since
2025/06/30
23.
State Street Corp(0.7861%)
since
2025/06/30
24.
Fidelity Small Cap Index(0.4528%)
since
2025/06/30
25.
Vanguard Institutional Extnd Mkt Idx Tr(0.4512%)
since
2025/07/31
26.
iShares Russell 2000 Value ETF(0.392%)
since
2025/08/31
27.
iShares Biotechnology ETF(0.3568%)
since
2025/08/31
28.
UTM IM GBP AXA Framlington Biotech(0.231%)
since
2025/07/31
29.
Vanguard Russell 2000 ETF(0.2164%)
since
2025/07/31
30.
Fidelity Extended Market Index(0.2124%)
since
2025/07/31
31.
Victory Science & Technology(0.2017%)
since
2025/06/30
32.
Multi-Manager Small Cap Eq Strat Inst(0.1961%)
since
2025/07/31
33.
Schwab US Small-Cap ETF™(0.1942%)
since
2025/08/30
34.
State St Russell Sm Cap® Indx SL Cl I(0.1396%)
since
2025/08/31
35.
Schwab Small Cap Index(0.1136%)
since
2025/07/31
36.
NT R2000 Index Fund - NL(0.1093%)
since
2025/06/30
37.
iShares Micro-Cap ETF(0.102%)
since
2025/08/31
38.
Vanguard Health Care ETF(0.0885%)
since
2025/07/31
39.
NT R2000 Index Fund - DC - NL - 3(0.0872%)
since
2025/06/30
40.
Extended Equity Market Fund K(0.0836%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.5
EPS Estimate
-0.5014
EPS Difference
0.0014
Surprise Percent
0.2792%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.